<?xml version="1.0"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-05-18T15:20:58Z</responseDate><request verb="GetRecord" metadataPrefix="oai_dc">https://repository.lib.bcit.ca/oai/request</request><GetRecord><record><header><identifier>oai:repository.lib.bcit.ca:node-309</identifier><datestamp>2025-04-15T17:22:55Z</datestamp><setSpec>node:295</setSpec><setSpec>oai_pmh:all_repository_items</setSpec></header><metadata><oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Assessing Metro Vancouver residents&#039; knowledge and opinions of psilocybin.</dc:title>
                  <dc:description>Psilocybin is a naturally occurring hallucinogen found in different species of fungi. Psilocybin has gained extensive social popularity and political attention in the United States. Research has shown that psilocybin and psychological therapy may have promising therapeutic applications for safer and more effective treatment of mental illnesses such as major depressive disorder, addiction, anxiety, and obsessive-compulsive disorder. Psilocybin remains an illegal substance in Canada, and the current data on awareness, opinions, and use of psilocybin among Canadian adults are subpar. Further research on the health effects and clinical use of psilocybin is needed before any conclusions can be made. Addressing the current lack of reliable information about psilocybin among Canadians would be a sensible start.</dc:description>
                  <dc:date>2023</dc:date>
                  <dc:language>English</dc:language>
                  <dc:contributor>Baharmand, Payman</dc:contributor>
          <dc:contributor>Kambo, Amardeep</dc:contributor>
          <dc:contributor>British Columbia Institute of Technology School of Health Sciences</dc:contributor>
                  <dc:format>PDF</dc:format>
                  <dc:publisher>British Columbia Institute of Technology</dc:publisher>
                  <dc:type>Text</dc:type>
                  <dc:rights>This license enables reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator. CC BY-NC-ND includes the following elements: BY: credit must be given to the creator. NC: Only noncommercial uses of the work are permitted. ND: No derivatives or adaptations of the work are permitted. https://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
                  <dc:subject>Consumer behavior</dc:subject>
          <dc:subject>Mental health</dc:subject>
          <dc:subject>Psilocybin</dc:subject>
          <dc:subject>Therapy</dc:subject></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>
